Skip to main content
. 2021 Jan 8;22(1):141–145. doi: 10.1007/s12663-020-01503-y

Table 1.

Cases of SCH head and neck reported till date

Sl. no Author/year Site Age/gender Immunohistochemistry Size of lesion (in cm) Follow-up
1. Scott and Rosei 1988 [7] Ear 70/M NR NR NR
2. Tosios 1995 [8] Mandibular vestibule 12/F

HAM56 and vimentin positive in lining endothelial cells

Factor Vlll positive in endothelial cells and round vacuolated cells

Vimentin positive in epithelioid cells and majority of spindle cells

PCNA positive in less than 3% of the tumour cells

1 LF
3. Baron 2002 [9] Lateral nasal side wall 17 months/M NR 1 × 1 24 FOR
4. Ide 2004 [10] Palate 55/M CD31 positivity 1.2 NR
5. Lade 2005 [11] Posterior pharyngeal wall 25/M NR 6 48 FOR
6. Sheehan 2007 Buccal mucosa 44/M CD31 and CD34 positive. 1.2 NR
7. Tosios 2008 [12] Upper lip 29/F

CD34 and factor-VIII positive in endothelial cells and epithelioid cells

Smooth-muscle actin positive in endothelial cells and spindle cells

Few CD68 positive cells were seen in the solid areas

1 36 FOR
8. Minagawa 2011 [13] Temporal muscle 67/F NR 4 24
9. Cai et al. 2013 [14] Lower Lip 34/F Vimentin and α-SMA positive and CD31, CD34 and D2-40S-100 protein, keratin (AE1/AE3) and CK19 were negative in spindle cell component 2 NR
10. Higashino 2014 [15] Occipital region 37/F NR 2.5 NR
11. Gbolahan 2015 [16] Orbit 9/F CD34 positive 8 × 6 21 FOR
12 Sapariya 2015 [17] Thyroid 30/F

Thyroid follicles with thyroglobulin positivity

Endothelial cells with strong positivity for CD 34 and factor-VIII

Spindle cells positive for vimentin and negative for thyroglobulin, CD 34 and factor-VIII

4.3 × 2.8 NR
13. Chhava 2015 [18] Floor of mouth 33/M CD-31, CD-34 positive in spindle cells and endothelial cells 1 × 1.5 6 FOR
14. French 2016 [19] Tongue 52/F CD31 positive in spindle cells and endothelial cells 2 24 FOR
15. Murakami 2018 [20] Upper lip 41/F CD34 and SMA positive in most endothelial cells and occasional spindle cells 3 24FOR
16. Present case 2020 Lower lip 32/M CD 31 positive in endothelial cells and occasional spindle cells. 2.5 8FOR

NR not reported, FOR Free of recurrence, LF Lost to follow-up